ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,861Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 247

$2.06M Total Retail Price of All Prescriptions

Rank: 1 out of 247

1,272 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

30% of this provider’s 1,272 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 12,186 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$139 was the average price of a prescription from this provider, compared to $147 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METHOTREXATE 1,977 1,599 10 1 2
PREDNISONE 1,330 1,060 2 1
HYDROCODONE-ACETAMINOPHEN 1,015 862 S3 3 4
FOLIC ACID 979 816 10 4 16
OMEPRAZOLE 543 411 5 12
MELOXICAM 540 470 6 6
VOLTAREN 486 432 7 22
TRAMADOL HCL 473 427 8 5
ENBREL 356 267 10 9 11
HUMIRA 334 212 10 19
HYDROXYCHLOROQUINE SULFATE 331 242 11 3
NAPROXEN 328 269 12 26
GABAPENTIN 323 294 13 7
IBUPROFEN 301 237 14 36
ALENDRONATE SODIUM 277 260 15 8
ACETAMINOPHEN-CODEINE 276 215 S3 16 51
CELEBREX 207 149 17 10
IBANDRONATE SODIUM 199 180 18 49
ACTONEL 191 182 19 32
ZOLPIDEM TARTRATE 182 150 20 20
DICLOFENAC SODIUM 174 141 21 21
BONIVA 164 150 22 66
LEFLUNOMIDE 159 107 23 9
ALLOPURINOL 150 127 24 14
LEUCOVORIN CALCIUM 119 112 25 37
LIDODERM 117 111 26 27
LYRICA 98 51 27 15
LEVOTHYROXINE SODIUM 97 85 28 25
FORTEO 96 96 29 30
PROLIA 89 81 30 63
AMLODIPINE BESYLATE 87 64 31 41
SIMVASTATIN 83 58 32 28
NEXIUM 78 60 33 66
DIOVAN 76 64 34 124
LISINOPRIL 75 64 35 47
ALPRAZOLAM 75 57 35 70
CYCLOBENZAPRINE HCL 70 55 R 37 17
ATENOLOL 70 58 37 55
ESCITALOPRAM OXALATE 64 58 39 85
PANTOPRAZOLE SODIUM 58 47 40 92
RANITIDINE HCL 56 53 41 82
COLCRYS 55 43 42 29
CYMBALTA 53 40 43 13
TRAMADOL HCL-ACETAMINOPHEN 51 45 44 23
LORAZEPAM 50 45 45 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.